{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:26:25Z","timestamp":1793597185968,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["MR\/S003800\/1"],"award-info":[{"award-number":["MR\/S003800\/1"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010756","name":"Health and Social Care Research and Development Division","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.seizure.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:57:56Z","timestamp":1755241076000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Educational outcomes associated with prenatal exposure to antiseizure medications: A systematic literature review and meta-Analysis"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0987-9974","authenticated-orcid":false,"given":"Alexia","family":"Karain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama A.","family":"Shakhshir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.seizure.2025.08.016_bib0001","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10309-023-00603-2","article-title":"The importance of pregnancy registries for the management of women with epilepsy and childbearing potential: emphasis on EURAP","volume":"36","author":"Tomson","year":"2023","journal-title":"Clin Epileptol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0002","series-title":"Standards of care for women with epilepsy of childbearing age","author":"Stephen","year":"2023"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaneurol.2019.0447","article-title":"Antiepileptic drug treatment patterns in women of childbearing age with epilepsy","volume":"76","author":"Kim","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074630","article-title":"Management of epilepsy during pregnancy and lactation","volume":"382","author":"Hope","year":"2023","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.seizure.2025.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1080\/14740338.2022.2160443","article-title":"Current safety concerns about the use of antiseizure medications in pregnancy","volume":"21","author":"Falcicchio","year":"2022","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"10.1016\/j.seizure.2025.08.016_bib0006","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867417726175","article-title":"Mood stabilizers in pregnancy and child developmental outcomes: a systematic review","volume":"51","author":"Haskey","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"10.1016\/j.seizure.2025.08.016_bib0007","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.08.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108666","article-title":"Trends in antiseizure medication prescription patterns among adults, women, and older adults with epilepsy: a German longitudinal analysis from 2008 to 2020","volume":"130","author":"Hochbaum","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.08.016_bib0009","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00381-019-04435-2","article-title":"The impact of maternal epilepsy on delivery and neonatal outcomes","volume":"36","author":"Melikova","year":"2020","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.seizure.2025.08.016_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40120-021-00252-5","article-title":"Pregnancy and the control of epileptic seizures: a review","volume":"10","author":"Eadie","year":"2021","journal-title":"Neurol Ther"},{"issue":"10","key":"10.1016\/j.seizure.2025.08.016_bib0011","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archneurol.2011.133","article-title":"Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations","volume":"68","author":"Holmes","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108904","article-title":"Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: an observation study in northwest China","volume":"135","author":"Shi","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.seizure.2025.08.016_bib0013","doi-asserted-by":"crossref","first-page":"e3287","DOI":"10.1002\/brb3.3287","article-title":"The impact of epilepsy and antiseizure medications on pregnancy and neonatal outcomes: a nationwide cohort study","volume":"13","author":"Kuo","year":"2023","journal-title":"Brain Behav"},{"key":"10.1016\/j.seizure.2025.08.016_bib0014","article-title":"Antiseizure medication use during pregnancy and neonatal growth outcomes: a systematic review and meta-analysis","author":"Lavu","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.seizure.2025.08.016_bib0015","article-title":"Women with epilepsy: anti-epileptic drugs and perinatal outcomes","volume":"11","author":"Kashif","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.seizure.2025.08.016_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yebeh.2018.09.033","article-title":"Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancy","volume":"92","author":"Putignano","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.seizure.2025.08.016_bib0017","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1111\/bcp.15413","article-title":"Adverse fetal and neonatal outcomes following in utero exposure to oxcarbazepine: a systematic review and meta-analysis","volume":"88","author":"Athar","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.seizure.2025.08.016_bib0018","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.seizure.2025.08.016_bib0019","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/epi.16953","article-title":"Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review","volume":"62","author":"Knight","year":"2021","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.seizure.2025.08.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209175","article-title":"Neurodevelopmental and functional outcomes following in utero exposure to antiseizure medication: a systematic review","volume":"102","author":"Honybun","year":"2024","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.seizure.2025.08.016_bib0021","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer-term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.seizure.2025.08.016_bib0022","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp-2018-318386","article-title":"In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring","volume":"89","author":"Bech","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.seizure.2025.08.016_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpn.2014.09.006","article-title":"Pregnancy and neurodevelopmental outcomes with in-utero antiepileptic agent exposure: a pilot study","volume":"19","author":"Arkilo","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0025","first-page":"37","article-title":"Developmental and behavioral consequences of intrauterine anti-seizure medication exposure","volume":"60","author":"Ya\u015fg\u00fc\u00e7l\u00fckal","year":"2023","journal-title":"Arch Neuropsychiatry"},{"key":"10.1016\/j.seizure.2025.08.016_bib0026","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"83","article-title":"Defining the review question and developing criteria for including studies","author":"O\u2019Connor","year":"2008"},{"issue":"5","key":"10.1016\/j.seizure.2025.08.016_bib0027","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.seizure.2025.08.016_bib0028","unstructured":"Wells G.A., Shea B., O\u2019Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 1 Sep 2024."},{"key":"10.1016\/j.seizure.2025.08.016_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"issue":"6","key":"10.1016\/j.seizure.2025.08.016_bib0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children","volume":"75","author":"Elkj\u00e6r","year":"2018","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2025.08.016_bib0031","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1528-1167.2010.02778.x","article-title":"School performance at age 16 in children exposed to antiepileptic drugs in utero: a population-based study","volume":"52","author":"Forsberg","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0032","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jnnp-2017-317515","article-title":"Educational attainment of children born to mothers with epilepsy","volume":"89","author":"Lacey","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0033","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1212\/WNL.0000000000201529","article-title":"Prenatal carbamazepine exposure and academic performance in adolescents: a population-based cohort study","volume":"100","author":"Ren","year":"2023","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0034","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.seizure.2025.08.016_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2022.06.005","article-title":"Language, intelligence, and educational outcomes of adolescents with antenatal exposure to antiseizure medications: prospective data from the Kerala Registry of epilepsy and pregnancy","volume":"100","author":"Thomas","year":"2022","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.seizure.2025.08.016_bib0037","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2025.08.016_bib0038","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.39.4.251","article-title":"Long-term health and neurodevelopment in children exposed to antiepileptic drugs before birth","volume":"39","author":"Dean","year":"2002","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.seizure.2025.08.016_bib0039","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1651-2227.2000.tb00333.x","article-title":"Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems","volume":"89","author":"Dessens","year":"2000","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.seizure.2025.08.016_bib0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3476(88)80269-5","article-title":"Family studies in fetal phenytoin exposure","volume":"113","author":"Van Dyke","year":"1988","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.seizure.2025.08.016_bib0041","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.yebeh.2006.08.007","article-title":"The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children","volume":"9","author":"Viinikainen","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9378(91)90640-D","article-title":"Antiepileptic medication in pregnancy: late effects on the children\u2019s central nervous system development","volume":"164","author":"van der Pol","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0043","unstructured":"National Perinatal Epidemiology Unit. UKOSS: completed surveillance - Epi. Oxford: National Perinatal Epidemiology Unit; [cited 2024 Dec 1]. Available from: https:\/\/www.npeu.ox.ac.uk\/ukoss\/completed-surveillance\/epi."},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0044","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis","volume":"7","author":"Veroniki","year":"2017","journal-title":"BMJ open"},{"issue":"11","key":"10.1016\/j.seizure.2025.08.016_bib0045","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/epi.16685","article-title":"Enduring language deficits in children of women with epilepsy and the potential role of intrauterine exposure to antiepileptic drugs","volume":"61","author":"Unnikrishnan","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.08.016_bib0046","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yebeh.2018.12.031","article-title":"Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: the NEAD prospective observational study","volume":"92","author":"Cohen","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.08.016_bib0047","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0048","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0049","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12884-023-06242-9","article-title":"Neurodevelopmental outcomes after prenatal exposure to lamotrigine monotherapy in women with epilepsy: a systematic review and meta-analysis","volume":"24","author":"Peron","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.seizure.2025.08.016_bib0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/11317640-000000000-00000","article-title":"Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies","volume":"33","author":"Banach","year":"2010","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.016_bib0051","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13643-021-01711-8","article-title":"Anti-epileptic drug exposure during pregnancy and neonatal birth weight outcomes: protocol for a systematic review and meta-analysis","volume":"10","author":"Lavu","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.seizure.2025.08.016_bib0052","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.seizure.2023.01.008","article-title":"Adaptive behaviour in children exposed to topiramate in the womb: an observational cohort study","volume":"105","author":"Knight","year":"2023","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0053","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.016_bib0054","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/10408444.2024.2368552","article-title":"Mechanisms of neurodevelopmental toxicity of topiramate","volume":"54","author":"Steele","year":"2024","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.seizure.2025.08.016_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108404","article-title":"Pre-pregnancy counseling for women with epilepsy: can we do better?","volume":"125","author":"Rakitin","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.08.016_bib0057","article-title":"Neurologists\u2019 and obstetricians\u2019 perspectives and current practices in breastfeeding counseling in women with epilepsy","volume":"156","author":"AO","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2025.08.016_bib0058","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200177","article-title":"Counseling on the need for folic acid in adolescents with epilepsy","volume":"13","author":"Lo","year":"2023","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.seizure.2025.08.016_bib0059","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/epi.16435","article-title":"Mortality and morbidity of patients with treated and untreated epilepsy in New Zealand","volume":"61","author":"Hamilton","year":"2020","journal-title":"Epilepsia"},{"issue":"25","key":"10.1016\/j.seizure.2025.08.016_bib0060","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1080\/14767058.2021.1938528","article-title":"Maternal morbidity and mortality associated with epilepsy","volume":"35","author":"Gyamfi-Bannerman","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.seizure.2025.08.016_bib0061","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.2375","article-title":"Risk of perinatal and maternal morbidity and mortality among pregnant women with epilepsy","volume":"79","author":"Razaz","year":"2024","journal-title":"JAMA Neurol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:28:50Z","timestamp":1793593730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"alternative-id":["S1059131125002092"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.08.016","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Educational outcomes associated with prenatal exposure to antiseizure medications: A systematic literature review and meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}